1. Centers for Disease Control and Prevention (CDC) . COVID data tracker. https://covid.cdc.gov/covid-data-tracker/#datatracker-home. Accessed July 22, 2021.
Google Scholar2. Abate, SM, Ahmed Ali, S, Mantfardo, B, Basu, B. Rate of Intensive Care Unit admission and outcomes among patients with coronavirus: a systematic review and meta-analysis. PLoS One. 2020;15(7):e0235653. doi:10.1371/journal.pone.0235653.
Google Scholar | Crossref | Medline3. Rawal, G, Yadav, S, Kumer, R. Post-intensive care syndrome: an overview. J Transl Int Med. 2017;5(2):90-92. doi:10.1515/jtim-2016-0016.
Google Scholar | Crossref | Medline4. Hirshberg, EL, Wilson, EL, Stanfield, V, et al. Impact of critical illness on resource utilization: a comparison of use in the year before and after ICU admission. Crit Care Med. 2019;47(11):1497-1504. doi:10.1097/CCM.0000000000003970.
Google Scholar | Crossref | Medline5. Needham, DM, Davidson, J, Cohen, H, et al. Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders’ conference. Crit Care Med. 2012;40(2):502-509. doi:10.1097/CCM.0b013e318232da75.
Google Scholar | Crossref6. Society of Critical Care Medicine . Post-intensive care syndrome. https://www.sccm.org/MyICUCare/THRIVE/Post-intensive-Care-Syndrome. Accessed July 22, 2021.
Google Scholar7. Tully, AP, Hammond, DA, Li, C, Jarrell, AS, Kruer, RM. Evaluation of medication errors at the transition of care from an ICU to non-ICU location. Crit Care Med. 2019;47(4):543-549. doi:10.1097/CCM.0000000000003633.
Google Scholar | Crossref | Medline8. Morandi, A, Vasilevskis, E, Pandharipande, PP, et al. Inappropriate medication prescriptions in elderly adults surviving an intensive care unit hospitalization. J Am Geriatr Soc. 2013;61(7):1128-1134. doi:10.1111/jgs.12329.
Google Scholar | Crossref | Medline9. Mohammad, RA, Betthauser, KD, Bookstavor, R, et al. Clinical pharmacist services within intensive care unit recovery clinics: an opinion of the critical care practice and research network of the American College of Clinical Pharmacy. J Am Coll Clin Pharm. 2020;3:1369-1379. doi:10.1002/jac5.1311.
Google Scholar | Crossref10. Di Fusco, M, Shea, KM, Lin, J, et al. Health outcomes and economic burden of hospitalized COVID-19 patients in the United States. J Med Econ. 2021;24(1):308-317. doi:10.1080/13696998.2021.1886109.
Google Scholar | Crossref | Medline11. Tsai, Y, Vogt, TM, Zhou, F. Patient characteristics and costs associated with COVID-19-related medical care among medicare fee-for-service beneficiaries. Ann Intern Med. 2021;174(8):1101-1109. doi:10.7326/M21-1102.
Google Scholar | Crossref | Medline12. Coe, AB, Vincent, BM, Iwashyna, TJ. Statin discontinuation and new antipsychotic use after an acute hospital stay vary by hospital. PLoS One. 2020;15(5):e0232707. doi:10.1371/journal.pone.0232707.
Google Scholar | Crossref | Medline13. Tomichek, JE, Stollings, JL, Pandharipande, PP, Chandrasekhar, R, Ely, EW, Girard, TD. Antipsychotic prescribing patterns during and after critical illness: a prospective cohort study. Crit Care. 2016;20(1):378. doi:10.1186/s13054-016-1557-1.
Google Scholar | Crossref | Medline14. Moore, C, Wisnivesky, J, Williams, S, McGinn, T. Medical errors related to discontinuity of care from an inpatient to an outpatient setting. J Gen Intern Med. 2003;18(8):646-651. doi:10.1046/j.1525-1497.2003.20722.x.
Google Scholar | Crossref | Medline | ISI15. Blanco, JR, Cobos-Ceballos, MJ, Navarro, F, et al. Pulmonary long-term consequences of COVID-19 infections after hospital discharge. Clin Microbiol Infect. 2021;27(6):892-896. doi:10.1016/j.cmi.2021.02.019.
Google Scholar | Crossref | Medline16. van Gassel, RJJ, Bels, JLM, Raafs, A, et al. High prevalence of pulmonary sequelae at 3 months after hospital discharge in mechanically ventilated survivors of COVID-19. Am J Respir Crit Care Med. 2021;203(3):371-374. doi:10.1164/rccm.202010-3823LE.
Google Scholar | Crossref | Medline17. Ayoubkhani, D, Khunti, K, Nafilyan, V, et al. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693. doi:10.1136/bmj.n693.
Google Scholar | Crossref | Medline18. Nopp, S, Moik, F, Jilma, B, Pabinger, I, Ay, C. Risk of venous thromboembolism in patients with COVID-19: a systematic review and meta-analysis. Res Pract Thromb Haemost. 2020;4(7):1178-1191. doi:10.1002/rth2.12439.
Google Scholar | Crossref19. Bikdeli, B, Madhavan, MV, Jimenez, D, et al; Global COVID-19 Thrombosis Collaborative Group, Endorsed by the ISTH, NATF, ESVM, and the IUA, Supported by the ESC Working Group on Pulmonary Circulation and Right Ventricular Function . COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020;75(23):2950-2973. doi:10.1016/j.jacc.2020.04.031.
Google Scholar | Crossref | Medline20. Kaplan, D, Casper, TC, Elliott, CG, et al. VTE incidence and risk factors in patients with severe sepsis and septic shock. Chest. 2015;148(5):1224-1230. doi:10.1378/chest.15-0287.
Google Scholar | Crossref | Medline | ISI21. Spyropoulos, AC, Weitz, JI. Hospitalized COVID-19 patients and venous thromboembolism: a perfect storm. Circulation. 2020;142(2):129-132. doi:10.1161/CIRCULATIONAHA.120.048020.
Google Scholar | Crossref | Medline22. Lim, S, Bae, JH, Kwon, HS, Nauck, MA. COVID-19 and diabetes mellitus: from pathophysiology to clinical management. Nat Rev Endocrinol. 2021;17(1):11-30. doi:10.1038/s41574-020-00435-4.
Google Scholar | Crossref | Medline23. Sathish, T, Kapoor, N, Cao, Y, Tapp, RJ, Zimmet, P. Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis. Diabetes Obes Metab. 2021;23(3):870-874. doi:10.1111/dom.14269.
Google Scholar | Crossref | Medline24. Li, B, Yang, J, Zhao, F, et al. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020;109(5):531-538. doi:10.1007/s00392-020-01626-9.
Google Scholar | Crossref | Medline25. Chen, J, Wu, C, Wang, X, Yu, J, Sun, Z. The impact of COVID-19 on blood glucose: a systematic review and meta-analysis. Front Endocrinol (Lausanne). 2020;11:574-541. doi:10.3389/fendo.2020.574541.
Google Scholar | Crossref | Medline26. Montefusco, L, Ben Nasr, M, D’Addio, F, et al. Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection. Nat Metab. 2021;3(6):774-785. doi:10.1038/s42255-021-00407-6.
Google Scholar | Crossref | Medline